2025 |
Climb Bio Inc.
|
Director |
- |
- |
2024 |
Acumen Pharmaceuticals Inc
|
Independent Director |
107.8 K |
-29.2 % |
2024 |
LENZ Therapeutics Inc.
|
Independent Director |
- |
- |
2024 |
Climb Bio Inc.
|
Independent Director |
- |
- |
2023 |
Acumen Pharmaceuticals Inc
|
Independent Director |
152.3 K |
-39.8 % |
2023 |
Kineta Inc
|
Independent Director |
69.8 K |
45.9 % |
2023 |
Graphite Bio Inc
|
Director, President, Chief Executive Officer, Prin |
- |
- |
2023 |
Graphite Bio Inc
|
Director, President, Chief Executive Officer, Prin |
- |
- |
2022 |
Acumen Pharmaceuticals Inc
|
Independent Director |
253 K |
- |
2022 |
Kineta Inc
|
Director |
47.9 K |
- |
2021 |
Acumen Pharmaceuticals Inc
|
Independent Director |
- |
- |